AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer

Clinical trial NCT00770848 · COMPLETED

Trial details

NCT number: NCT00770848
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer Castrate-Resistant Prostate Cancer Mestastatic Prostate Cancer Prostate Cancer

Start date: 2008-11-01
Primary completion: 2011-01-01
Enrollment: 162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.